Cul3 regulates cyclin E1 protein abundance via a degron located within the N-terminal region of cyclin E

被引:14
作者
Davidge, Brittney [1 ,3 ]
Rebola, Katia Graziella de Oliveira [1 ]
Agbor, Larry N. [2 ,4 ]
Sigmund, Curt D. [2 ]
Singer, Jeffrey D. [1 ]
机构
[1] Portland State Univ, Dept Biol, Portland, OR 97201 USA
[2] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA
[3] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98109 USA
[4] DMT, Ann Arbor, MI 48108 USA
基金
美国国家卫生研究院;
关键词
Cul3; Cyclin E; Cancer; G1/S transition; Ubiquitin; MOLECULAR-WEIGHT FORMS; E OVEREXPRESSION; CELL-CYCLE; G1; CYCLIN; CDK2; PHOSPHORYLATION; UBIQUITINATION; HYPERTENSION; TURNOVER; ADAPTER;
D O I
10.1242/jcs.233049
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cyclin E and its binding partner Cdk2 control the G1/S transition in mammalian cells. Increased levels of cyclin E are found in some cancers. Additionally, proteolytic removal of the cyclin E N-terminus occurs in some cancers and is associated with increased cyclin E-Cdk2 activity and poor clinical prognosis. Cyclin E levels are tightly regulated and controlled in part through ubiquitin-mediated degradation initiated by one of two E3 ligases, Cul1 and Cul3. Cul1 ubiquitylates phosphorylated cyclin E, but the mechanism through which Cul3 ubiquitylates cyclin E is poorly understood. In experiments to ascertain how Cul3 mediates cyclin E destruction, we identified a degron on cyclin E that Cul3 targets for ubiquitylation. Recognition of the degron and binding of Cul3 does not require a BTB domain-containing adaptor protein. Additionally, this degron is lacking in N-terminally truncated cyclin E. Our results describe a mechanism whereby N-terminally truncated cyclin E can avoid the Cul3-mediated degradation pathway. This mechanism helps to explain the increased activity that is associated with the truncated cyclin E variants that occurs in some cancers.
引用
收藏
页数:14
相关论文
共 59 条
  • [1] Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p2l, p27, and antiestrogens in breast cancer
    Akli, S
    Zheng, PJ
    Multani, AS
    Wingate, HF
    Pathak, S
    Zhang, N
    Tucker, SL
    Chang, S
    Keyomarsi, K
    [J]. CANCER RESEARCH, 2004, 64 (09) : 3198 - 3208
  • [2] Low-Molecular-Weight Cyclin E Can Bypass Letrozole-Induced G1 Arrest in Human Breast Cancer Cells and Tumors
    Akli, Said
    Bui, Tuyen
    Wingate, Hannah
    Biernacka, Anna
    Moulder, Stacy
    Tucker, Susan L.
    Hunt, Kelly K.
    Keyomarsi, Khandan
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (04) : 1179 - 1190
  • [3] Low Molecular Weight Cyclin E Overexpression Shortens Mitosis, Leading to Chromosome Missegregation and Centrosome Amplification
    Bagheri-Yarmand, Rozita
    Biernacka, Anna
    Hunt, Kelly K.
    Keyomarsi, Khandan
    [J]. CANCER RESEARCH, 2010, 70 (12) : 5074 - 5084
  • [4] Fbw7α and Fbw7γ Collaborate To Shuttle Cyclin E1 into the Nucleolus for Multiubiquitylation
    Bhaskaran, Nimesh
    van Drogen, Frank
    Ng, Hwee-Fang
    Kumar, Raman
    Ekholm-Reed, Susanna
    Peter, Matthias
    Sangfelt, Olle
    Reed, Steven I.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2013, 33 (01) : 85 - 97
  • [5] Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities
    Boyden, Lynn M.
    Choi, Murim
    Choate, Keith A.
    Nelson-Williams, Carol J.
    Farhi, Anita
    Toka, Hakan R.
    Tikhonova, Irina R.
    Bjornson, Robert
    Mane, Shrikant M.
    Colussi, Giacomo
    Lebel, Marcel
    Gordon, Richard D.
    Semmekrot, Ben A.
    Poujol, Alain
    Valimaki, Matti J.
    De Ferrari, Maria E.
    Sanjad, Sami A.
    Gutkin, Michael
    Karet, Fiona E.
    Tucci, Joseph R.
    Stockigt, Jim R.
    Keppler-Noreuil, Kim M.
    Porter, Craig C.
    Anand, Sudhir K.
    Whiteford, Margo L.
    Davis, Ira D.
    Dewar, Stephanie B.
    Bettinelli, Alberto
    Fadrowski, Jeffrey J.
    Belsha, Craig W.
    Hunley, Tracy E.
    Nelson, Raoul D.
    Trachtman, Howard
    Cole, Trevor R. P.
    Pinsk, Maury
    Bockenhauer, Detlef
    Shenoy, Mohan
    Vaidyanathan, Priya
    Foreman, John W.
    Rasoulpour, Majid
    Thameem, Farook
    Al-Shahrouri, Hania Z.
    Radhakrishnan, Jai
    Gharavi, Ali G.
    Goilav, Beatrice
    Lifton, Richard P.
    [J]. NATURE, 2012, 482 (7383) : 98 - U126
  • [6] Cullin Mediates Degradation of RhoA through Evolutionarily Conserved BTB Adaptors to Control Actin Cytoskeleton Structure and Cell Movement
    Chen, Yuezhou
    Yang, Zhenxiao
    Meng, Min
    Zhao, Yue
    Dong, Na
    Yan, Hongming
    Liu, Liping
    Ding, Mingxiao
    Peng, H. Benjamin
    Shao, Feng
    [J]. MOLECULAR CELL, 2009, 35 (06) : 841 - 855
  • [7] DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer
    Choi, Y. M.
    Kim, K. B.
    Lee, J. H.
    Chun, Y. K.
    An, I. S.
    An, S.
    Bae, S.
    [J]. ONCOGENE, 2017, 36 (20) : 2802 - 2812
  • [8] CONFORMATION OF GLUCAGON - PREDICTIONS AND CONSEQUENCES
    CHOU, PY
    FASMAN, GD
    [J]. BIOCHEMISTRY, 1975, 14 (11) : 2536 - 2541
  • [9] Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation
    Clurman, BE
    Sheaff, RJ
    Thress, K
    Groudine, M
    Roberts, JM
    [J]. GENES & DEVELOPMENT, 1996, 10 (16) : 1979 - 1990
  • [10] The Cul3/Klhdc5 E3 Ligase Regulates p60/Katanin and Is Required for Normal Mitosis in Mammalian Cells
    Cummings, Cristina M.
    Bentley, Cornelia A.
    Perdue, Sarah A.
    Baas, Peter W.
    Singer, Jeffrey D.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (17) : 11663 - 11675